株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

緑茶エキス (EGCG) の世界市場:ニュートラシューティカル・化粧品・医薬品分野での市場機会の評価

Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019

発行 GervanoRA Data Services LLP 商品コード 833000
出版日 ページ情報 英文 103 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
緑茶エキス (EGCG) の世界市場:ニュートラシューティカル・化粧品・医薬品分野での市場機会の評価 Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019
出版日: 2019年04月26日 ページ情報: 英文 103 Pages
概要

当レポートでは、世界の緑茶エキス - EGCG (没食子酸エピガロカテキン) など - の市場について分析し、製品の概要・成分や抽出技術、主な活用分野、用途別の市場動向の見通し、現在の治験の進展状況、主要企業のプロファイルとSWOT分析、といった情報を取りまとめてお届けいたします。

第1章 イントロダクション

第2章 エグゼクティブ・サマリー

  • 分析概略
  • 昨今の市場の主な動き
  • 主な分析結果
    • 市場促進要因
    • 市場抑制要因
    • アンメットニーズ・市場機会

第3章 緑茶エキスの概要

  • 全般的な考慮事項
    • 緑茶エキスの概略
    • 緑茶エキスの組成構造
    • 緑茶エキス産業の概要 - 将来展望

第4章 緑茶エキスの抽出技術

  • 直茶エキス抽出技術の開発
  • 直茶エキス抽出技術の傾向 - 現状と将来展望

第5章 緑茶エキスの市場機会の評価 (エンドユース別/用途別)

  • 緑茶エキス:ニュートラシューティカル分野での市場機会
    • サプリメント錠剤
    • 機能性食品
    • エネルギードリンク
  • 緑茶エキス:化粧品分野での市場機会
    • パーソナルケア用品
    • 美容サプリメント
  • 緑茶エキス:医薬品分野での市場機会
    • 症状別の利用機会

第6章 治験動向

  • 医薬品方面の治験動向
  • ニュートラシューティカル方面の治験動向
  • 化粧品方面の治験動向

第7章 競争動向:概略

  • 既存企業とSWOT分析

第8章 略語一覧

目次
Product Code: GERPH1312

The Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019 report provides in-depth insights with respect to the three major applications and is built to provide strategically important competitor information, analytics, and insights to formulate effective counter research and development strategies. The report offers comprehensive analytics on GTE competitive space by covering nutraceuticals, cosmetics and pharmaceutical segments to assess the unmet needs, drivers, restrains and opportunities.

The following segments provide detailed analytics covering the overall GTE competitive space:

  • Key Events in GTE competitive space
  • Major Drivers, Restraints and Unmet Needs & Opportunities
  • GTE Industry overview
  • Developments and Trends in its Extraction Technologies
  • End Use Opportunity Assessment
  • Clinical Developments
  • Competitive Landscape of Companies
  • Key Companies SWOT Analysis

Report is concentrated more on providing the future favorable opportunities and growth that can be expected in the Green Tea Extract (GTE) market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. METHODOLOGY
  • 1.3. ABOUT US: GERVANORA DATA SERVICES

2. EXECUTIVE SUMMARY

  • 2.1. REPORT SUMMARY
  • 2.2. KEY EVENTS IN GREEN TEA EXTRACT COMPETITIVE SPACE- RECENT DEVELOPMENTS
    • 2.2.1. KEY EVENTS IN THE PHARMACEUTICAL DOMAIN
    • 2.2.2. KEY EVENTS IN THE NUTRACEUTICAL DOMAIN
    • 2.2.3. KEY EVENTS IN THE COSMETICS DOMAIN
  • 2.3. MAJOR FINDINGS
    • 2.3.1. DRIVERS
    • 2.3.2. RESTRAINTS
    • 2.3.3. UNMET NEEDS AND OPPORTUNITIES

3. GREEN TEA EXTRACT OVERVIEW

  • 3.1. GENERAL CONSIDERATIONS
    • 3.1.1. BRIEF INTRODUCTION OF GREEN TEA EXTRACT
    • 3.1.2. COMPOSITION OF GREEN TEA EXTRACT
      • 3.1.2.1 EC (EPICATECHIN)
      • 3.1.2.2 EGC (EPIGALLOCATECHIN)
      • 3.1.2.3 ECG (EPICATECHIN GALLATE)
      • 3.1.2.4 EGCG (EPIGALLOCATECHIN-3-GALLATE)
      • 3.1.2.5 OTHER POLYPHENOLS
      • 3.1.2.6 CAFFEINE
    • 3.1.3. OVERVIEW OF GREEN TEA EXTRACT INDUSTRY - FUTURE PERSPECTIVES

4. GREEN TEA EXTRACT TECHNOLOGIES

  • 4.1. DEVELOPMENTS IN GREEN TEA EXTRACTION TECHNOLOGIES
  • 4.2. TRENDS IN GREEN TEA EXTRACTION TECHNOLOGIES- CURRENT STATUS AND FUTURE PROSPECTS

5. GREEN TEA EXTRACT OPPORTUNITIES ASSESSMENT (END USE OR APPLICATION SEGMENT)

  • 5.1. GREEN TEA EXTRACT OPPORTUNITIES IN NUTRACEUTICAL
    • 5.1.1. EGCG APPLICATIONS IN NUTRACEUTICAL
      • 5.1.1.1 DIETARY SUPPLEMENTAL PILLS
      • 5.1.1.2 FUNCTIONAL FOODS
      • 5.1.1.3 ENERGY DRINKS
  • 5.2. GREEN TEA EXTRACT OPPORTUNITIES IN COSMETICS
    • 5.2.1. EGCG APPLICATIONS IN COSMETICS
      • 5.2.1.1 PERSONAL CARE PRODUCTS
      • 5.2.1.2. BEAUTY SUPPLEMENTS
  • 5.3. GREEN TEA EXTRACT OPPORTUNITIES IN PHARMACEUTICALS
    • 5.3.1. EGCG APPLICATIONS IN PHARMACEUTICALS
      • 5.3.1.1 INDICATION WISE APPLICATIONS

5.3.1.1.1 APPLICATIONS IN ONCOLOGY

5.3.1.1.2 APPLICATIONS IN CARDIOVASCULAR

5.3.1.1.3 APPLICATIONS IN METABOLIC DISORDERS

5.3.1.1.4 APPLICATIONS IN INFLAMMATORY SKIN DISEASES

5.3.1.1.5 APPLICATIONS IN NEURODEGENERATIVE DISEASES

5.3.1.1.6 APPLICATIONS IN OBESITY

6. CLINICAL DEVELOPMENTS

  • 6.1. CLINICAL DEVELOPMENTS IN PHARMACEUTICALS
  • 6.2. CLINICAL DEVELOPMENTS IN NUTRACEUTICALS
  • 6.3. CLINICAL DEVELOPMENTS IN COSMETICS

7. OVERVIEW OF COMPETITIVE SEGMENT

  • 7.1. ESTABLISHED COMPANIES AND SWOT
    • 7.1.1. INDENA S.P.A
    • 7.1.2. TAIYO INTERNATIONAL
    • 7.1.3. BLUE CALIFORNIA
    • 7.1.4. HUNAN SUNFULL BIO-TECH CO. LTD
    • 7.1.5. TATE AND LYLE
    • 7.1.6. ROYAL DSM
    • 7.1.7. APPLIED FOOD SCIENCES, INC

8. ABBREVIATIONS

LIST OF FIGURES

  • FIGURE 01: PAST EVENTS IN THE GTE PHARMACEUTICAL MARKET SPACE, 2006 TILL DATE
  • FIGURE 02: FUTURE ESTIMATED PIPELINE MOLECULE APPROVALS
  • FIGURE 03: KEY EVENTS IN THE NUTRACEUTICAL MARKET SPACE
  • FIGURE 04: KEY EVENTS IN THE COSMETICS MARKET SPACE
  • FIGURE 05: TRADITIONAL GREEN TEA EXTRACTION TECHNIQUES
  • FIGURE 06: ADVANCED GREEN TEA EXTRACTION TECHNOLOGIES
  • FIGURE 07: EGCG OPPORTUNITIES IN COSMETICS
  • FIGURE 08: INDENA MARKET OVERVIEW, GLOBAL
  • FIGURE 09: ANNUAL REVENUES (FY ENDED MARCH IN $M), TATE AND LYLE
  • FIGURE 10: ANNUAL REVENUES BY BUSINESS SEGMENTS, TATA AND LYLE
  • FIGURE 11: ANNUAL REVENUES SHARE OF BUSINESS SEGMENTS, DSM
  • FIGURE 12: DSM SALES BY DESTINATION REGIONS

LIST OF TABLES

  • TABLE 01: UNIVERSITIES AND INSTITUTES IN GTE RESEARCH
  • TABLE 02: EGCG OPPORTUNITIES IN OBESITY CONTROL
  • TABLE 03: EGCG OPPORTUNITIES IN ONCOLOGY
  • TABLE 04: EGCG OPPORTUNITIES IN DIABETES
  • TABLE 05: EGCG OPPORTUNITIES IN NEURODEGENERATIVE DISEASES
  • TABLE 06: EGCG OPPORTUNITIES IN LIVER DISEASES
  • TABLE 07: ASSESSMENT OF STUDIES FOR EGCG OPPORTUNITIES IN NUTRACEUTICALS
  • TABLE 08: OPPORTUNITY FINDINGS OF EGCG IN COSMETICS
  • TABLE 09: EGCG APPLICATIONS IN ONCOLOGY
  • TABLE 10: EGCG APPLICATIONS IN CARDIOVASCULAR DISEASES
  • TABLE 11: EGCG APPLICATIONS IN METABOLIC DISORDERS
  • TABLE 12: EGCG APPLICATIONS IN INFLAMMATROY SKIN DISEASES
  • TABLE 13: EGCG APPLICATIONS IN NEURODEGENRATIVE DISEASES
  • TABLE 14: EGCG APPLICATIONS IN OBESITY
  • TABLE 15: CLINICAL TRIALS IN PHARMACEUTICALS
  • TABLE 16: CLINICAL TRIALS IN NUTRACEUTICALS
Back to Top